MATRITECH INC/DE/
10-Q, EX-27, 2000-11-08
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: MATRITECH INC/DE/, 10-Q, 2000-11-08
Next: PRAXAIR INC, SC 13G/A, 2000-11-08



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                       4,677,146
<SECURITIES>                                         0
<RECEIVABLES>                                  219,009
<ALLOWANCES>                                         0
<INVENTORY>                                    408,130
<CURRENT-ASSETS>                             5,472,840
<PP&E>                                       2,172,287
<DEPRECIATION>                             (1,389,353)
<TOTAL-ASSETS>                               6,624,938
<CURRENT-LIABILITIES>                        1,187,944
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       250,970
<OTHER-SE>                                   5,027,249
<TOTAL-LIABILITY-AND-EQUITY>                 6,624,938
<SALES>                                        775,738
<TOTAL-REVENUES>                               775,738
<CGS>                                          663,047
<TOTAL-COSTS>                                  663,047
<OTHER-EXPENSES>                             4,915,001
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              12,659
<INCOME-PRETAX>                            (4,814,969)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (4,814,969)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (4,814,969)
<EPS-BASIC>                                      (.20)
<EPS-DILUTED>                                    (.20)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission